You just read:

Panacea Pharmaceuticals Engages Accelovance For Clinical Development Of Its Novel Nanoparticle-Based Therapeutic Cancer Vaccine

News provided by

Panacea Pharmaceuticals, Inc.

Feb 10, 2015, 10:48 ET